Literature DB >> 28660287

Adverse outcome pathways: a concise introduction for toxicologists.

Mathieu Vinken1, Dries Knapen2, Lucia Vergauwen2,3, Jan G Hengstler4, Michelle Angrish5, Maurice Whelan6.   

Abstract

Adverse outcome pathways (AOPs) are designed to provide a clear-cut mechanistic representation of critical toxicological effects that propagate over different layers of biological organization from the initial interaction of a chemical with a molecular target to an adverse outcome at the individual or population level. Adverse outcome pathways are currently gaining momentum, especially in view of their many potential applications as pragmatic tools in the fields of human toxicology, ecotoxicology, and risk assessment. A number of guidance documents, issued by the Organization for Economic Cooperation and Development, as well as landmark papers, outlining best practices to develop, assess and use AOPs, have been published in the last few years. The present paper provides a synopsis of the main principles related to the AOP framework for the toxicologist less familiar with this area, followed by two case studies relevant for human toxicology and ecotoxicology.

Entities:  

Keywords:  Adverse outcome pathway; Ecotoxicology; Risk assessment; Toxicology

Mesh:

Substances:

Year:  2017        PMID: 28660287      PMCID: PMC5805086          DOI: 10.1007/s00204-017-2020-z

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  53 in total

1.  Development of a peptide reactivity assay for screening contact allergens.

Authors:  G Frank Gerberick; Jeff D Vassallo; Ruth E Bailey; Joel G Chaney; Steve W Morrall; Jean-Pierre Lepoittevin
Journal:  Toxicol Sci       Date:  2004-07-14       Impact factor: 4.849

Review 2.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

3.  The identification of contact allergens by animal assay. The guinea pig maximization test.

Authors:  B Magnusson; A M Kligman
Journal:  J Invest Dermatol       Date:  1969-03       Impact factor: 8.551

4.  Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole part I: Fathead minnow.

Authors:  Krysta R Nelson; Anthony L Schroeder; Gerald T Ankley; Brett R Blackwell; Chad Blanksma; Sigmund J Degitz; Kevin M Flynn; Kathleen M Jensen; Rodney D Johnson; Michael D Kahl; Dries Knapen; Patricia A Kosian; Rebecca Y Milsk; Eric C Randolph; Travis Saari; Evelyn Stinckens; Lucia Vergauwen; Daniel L Villeneuve
Journal:  Aquat Toxicol       Date:  2016-01-07       Impact factor: 4.964

5.  Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances.

Authors:  Nathalie Hinfray; Jean-Marc Porcher; François Brion
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2006-09-26       Impact factor: 3.228

6.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis.

Authors:  C Sonich-Mullin; R Fielder; J Wiltse; K Baetcke; J Dempsey; P Fenner-Crisp; D Grant; M Hartley; A Knaap; D Kroese; I Mangelsdorf; E Meek; J M Rice; M Younes
Journal:  Regul Toxicol Pharmacol       Date:  2001-10       Impact factor: 3.271

7.  Editor's Highlight: Computational Modeling of Plasma Vitellogenin Alterations in Response to Aromatase Inhibition in Fathead Minnows.

Authors:  Wan-Yun Cheng; Qiang Zhang; Anthony Schroeder; Daniel L Villeneuve; Gerald T Ankley; Rory Conolly
Journal:  Toxicol Sci       Date:  2016-08-07       Impact factor: 4.849

Review 8.  IPCS framework for analyzing the relevance of a noncancer mode of action for humans.

Authors:  Alan R Boobis; John E Doe; Barbara Heinrich-Hirsch; M E Bette Meek; Sharon Munn; Mathuros Ruchirawat; Josef Schlatter; Jennifer Seed; Carolyn Vickers
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

9.  Adverse Outcome Pathways can drive non-animal approaches for safety assessment.

Authors:  Natalie Burden; Fiona Sewell; Melvin E Andersen; Alan Boobis; J Kevin Chipman; Mark T D Cronin; Thomas H Hutchinson; Ian Kimber; Maurice Whelan
Journal:  J Appl Toxicol       Date:  2015-05-05       Impact factor: 3.446

10.  How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology.

Authors:  Clemens Wittwehr; Hristo Aladjov; Gerald Ankley; Hugh J Byrne; Joop de Knecht; Elmar Heinzle; Günter Klambauer; Brigitte Landesmann; Mirjam Luijten; Cameron MacKay; Gavin Maxwell; M E Bette Meek; Alicia Paini; Edward Perkins; Tomasz Sobanski; Dan Villeneuve; Katrina M Waters; Maurice Whelan
Journal:  Toxicol Sci       Date:  2016-12-19       Impact factor: 4.849

View more
  29 in total

1.  A method for CRISPR/Cas9 mutation of genes in fathead minnow (Pimephales promelas).

Authors:  Jennifer A Maki; Jenna E Cavallin; Kevin G Lott; Travis W Saari; Gerald T Ankley; Daniel L Villeneuve
Journal:  Aquat Toxicol       Date:  2020-03-02       Impact factor: 4.964

2.  Leveraging the Comparative Toxicogenomics Database to Fill in Knowledge Gaps for Environmental Health: A Test Case for Air Pollution-induced Cardiovascular Disease.

Authors:  Allan Peter Davis; Thomas C Wiegers; Cynthia J Grondin; Robin J Johnson; Daniela Sciaky; Jolene Wiegers; Carolyn J Mattingly
Journal:  Toxicol Sci       Date:  2020-10-01       Impact factor: 4.849

3.  The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology.

Authors:  Gerald T Ankley; Stephen W Edwards
Journal:  Curr Opin Toxicol       Date:  2018-06-01

4.  A Rat Liver Transcriptomic Point of Departure Predicts a Prospective Liver or Non-liver Apical Point of Departure.

Authors:  Kamin J Johnson; Scott S Auerbach; Eduardo Costa
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

Review 5.  Overview of Adverse Outcome Pathways and Current Applications on Nanomaterials.

Authors:  Dora Rolo; Ana Tavares; Nádia Vital; Maria João Silva; Henriqueta Louro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro.

Authors:  Jördis Klose; Lu Li; Xiaohui Fan; Ellen Fritsche; Melanie Pahl; Farina Bendt; Ulrike Hübenthal; Christian Jüngst; Patrick Petzsch; Astrid Schauss; Karl Köhrer; Ping Chung Leung; Chi Chiu Wang; Katharina Koch; Julia Tigges
Journal:  Cell Biol Toxicol       Date:  2022-06-15       Impact factor: 6.691

Review 7.  A decade of toxicological trends: what the papers say.

Authors:  Phumzile Sikakana; Ruth A Roberts
Journal:  Toxicol Res (Camb)       Date:  2020-10-08       Impact factor: 3.524

8.  Taking adverse outcome pathways to the next level.

Authors:  Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2018-04-06       Impact factor: 3.500

9.  In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.

Authors:  Mathieu Vinken
Journal:  Arch Toxicol       Date:  2018-03-24       Impact factor: 5.153

10.  Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures.

Authors:  Robim M Rodrigues; Laxmikanth Kollipara; Umesh Chaudhari; Agapios Sachinidis; René P Zahedi; Albert Sickmann; Annette Kopp-Schneider; Xiaoqi Jiang; Hector Keun; Jan Hengstler; Marlies Oorts; Pieter Annaert; Eef Hoeben; Eva Gijbels; Joery De Kock; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2018-05-14       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.